TY - JOUR
T1 - Docosahexaenoic acid induces proteasome-dependent degradation of beta-catenin, downregulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2.
AU - Calviello, Gabriella
AU - Resci, Federica
AU - Serini, Simona
AU - Piccioni, Elisabetta
AU - Toesca Di Castellazzo, Amelia
AU - Boninsegna Lucarelli, Alma
AU - Monego, Giovanni
AU - Ranelletti, Franco Oreste
AU - Palozza, Paola
PY - 2007
Y1 - 2007
N2 - n-3 Polyunsaturated fatty acids have been shown to powerfully inhibit the growth
of colon cancer cells, mainly acting as pro-apoptotic agents through inhibition
of COX-2 expression. Since dysregulation of beta-catenin expression is
frequently found at early stage of colorectal carcinogenesis, we analyzed
whether docosahexaenoic acid (DHA) may modify the expression of beta-catenin in
colon cancer cells (SW480 and HCT116) overexpressing this protein, but lacking
COX-2. Futhermore, we investigated if alterations in beta-catenin expression may
be associated with apoptosis induction. Treatment of cells with increasing
concentrations of DHA induced a dose- and time-dependent inhibition of
beta-catenin protein expression which, however, was not accompanied by
modifications in beta-catenin transcription. Conversely, the proteasomal
inhibitors MG132 and lactacystin prevented DHA-induced beta-catenin decrease,
suggesting that DHA may regulate the proteasomal degradation of beta-catenin.
The reduced levels of beta-catenin were accompanied by decreased translocation
of beta-catenin into the nucleus, where it acts as a transcription factor in
concert with TCF. DHA, at the same range of concentrations, was also able to
induce apoptosis by a caspase-3 dependent mechanism and to cause a dose- and
time-dependent decrease of survivin, an apoptosis inhibitor undetectable in
normal tissues and expressed in colorectal cancer through TCF/beta-catenin
stimulation. Several other proteins regulated by the TCF/beta-catenin pathway
and involved in regulation of tumor growth were down-regulated by DHA, including
PPAR-delta, MT1-MMP, MMP-7, and VEGF. The present study, thus, raises the
possibility that DHA may exert pro-apoptotic and antitumoral effects through
proteasomal regulation of beta-catenin levels and alterations in the expression
of TCF/beta-catenin-target genes.
AB - n-3 Polyunsaturated fatty acids have been shown to powerfully inhibit the growth
of colon cancer cells, mainly acting as pro-apoptotic agents through inhibition
of COX-2 expression. Since dysregulation of beta-catenin expression is
frequently found at early stage of colorectal carcinogenesis, we analyzed
whether docosahexaenoic acid (DHA) may modify the expression of beta-catenin in
colon cancer cells (SW480 and HCT116) overexpressing this protein, but lacking
COX-2. Futhermore, we investigated if alterations in beta-catenin expression may
be associated with apoptosis induction. Treatment of cells with increasing
concentrations of DHA induced a dose- and time-dependent inhibition of
beta-catenin protein expression which, however, was not accompanied by
modifications in beta-catenin transcription. Conversely, the proteasomal
inhibitors MG132 and lactacystin prevented DHA-induced beta-catenin decrease,
suggesting that DHA may regulate the proteasomal degradation of beta-catenin.
The reduced levels of beta-catenin were accompanied by decreased translocation
of beta-catenin into the nucleus, where it acts as a transcription factor in
concert with TCF. DHA, at the same range of concentrations, was also able to
induce apoptosis by a caspase-3 dependent mechanism and to cause a dose- and
time-dependent decrease of survivin, an apoptosis inhibitor undetectable in
normal tissues and expressed in colorectal cancer through TCF/beta-catenin
stimulation. Several other proteins regulated by the TCF/beta-catenin pathway
and involved in regulation of tumor growth were down-regulated by DHA, including
PPAR-delta, MT1-MMP, MMP-7, and VEGF. The present study, thus, raises the
possibility that DHA may exert pro-apoptotic and antitumoral effects through
proteasomal regulation of beta-catenin levels and alterations in the expression
of TCF/beta-catenin-target genes.
KW - COX-2
KW - Docosaesaenoic acid
KW - beta-catenin
KW - colon cancer
KW - COX-2
KW - Docosaesaenoic acid
KW - beta-catenin
KW - colon cancer
UR - http://hdl.handle.net/10807/20950
U2 - 10.1093/carcin/bgl254
DO - 10.1093/carcin/bgl254
M3 - Article
SN - 0143-3334
SP - 1202
EP - 1209
JO - Carcinogenesis
JF - Carcinogenesis
ER -